BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32747747)

  • 1. Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.
    Bashour SI; Ibrahim NK; Schomer DF; Hess KR; Gao C; Tripathy D; Fuller GN
    Br J Cancer; 2020 Oct; 123(9):1417-1423. PubMed ID: 32747747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
    Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
    Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
    Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
    Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
    Dawood S; Broglio K; Esteva FJ; Ibrahim NK; Kau SW; Islam R; Aldape KD; Yu TK; Hortobagyi GN; Gonzalez-Angulo AM
    Ann Oncol; 2008 Jul; 19(7):1242-1248. PubMed ID: 18334512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system metastases in breast cancer.
    Kiricuta IC; Kölbl O; Willner J; Bohndorf W
    J Cancer Res Clin Oncol; 1992; 118(7):542-6. PubMed ID: 1624546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs.
    Hurvitz SA; O'Shaughnessy J; Mason G; Yardley DA; Jahanzeb M; Brufsky A; Rugo HS; Swain SM; Kaufman PA; Tripathy D; Chu L; Li H; Antao V; Cobleigh M
    Clin Cancer Res; 2019 Apr; 25(8):2433-2441. PubMed ID: 30593513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
    Song Y; Barry WT; Seah DS; Tung NM; Garber JE; Lin NU
    Cancer; 2020 Jan; 126(2):271-280. PubMed ID: 31581314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
    Cacho-Díaz B; Salmerón-Moreno K; Alvarez-Alvarez A; Mendoza-Olivas LG; Alvarado-Miranda A; Villarreal-Garza C; Reynoso-Noverón N; Chávez-MacGregor M; Meneses-García AA
    Cancer; 2020 Aug; 126(15):3456-3463. PubMed ID: 32453447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management.
    Lin NU; Gaspar LE; Soffietti R
    Am Soc Clin Oncol Educ Book; 2017; 37():45-56. PubMed ID: 28561683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
    Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
    Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.
    Musolino A; Ciccolallo L; Panebianco M; Fontana E; Zanoni D; Bozzetti C; Michiara M; Silini EM; Ardizzoni A
    Cancer; 2011 May; 117(9):1837-46. PubMed ID: 21509760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study.
    Viot J; Bachour M; Meurisse A; Pivot X; Fiteni F
    Breast; 2017 Aug; 34():53-57. PubMed ID: 28505557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.
    Harputluoglu H; Dizdar O; Aksoy S; Kilickap S; Dede DS; Ozisik Y; Guler N; Barista I; Gullu I; Hayran M; Selek U; Cengiz M; Zorlu F; Tekuzman G; Altundag K
    J Natl Med Assoc; 2008 May; 100(5):521-6. PubMed ID: 18507204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer subtypes and central nervous system metastases.
    Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
    Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer subtypes and outcomes of central nervous system metastases.
    Arslan UY; Oksuzoglu B; Aksoy S; Harputluoglu H; Turker I; Ozisik Y; Dizdar O; Altundag K; Alkis N; Zengin N
    Breast; 2011 Dec; 20(6):562-7. PubMed ID: 21871802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her-2/neu status in breast cancer metastases to the central nervous system.
    Lear-Kaul KC; Yoon HR; Kleinschmidt-DeMasters BK; McGavran L; Singh M
    Arch Pathol Lab Med; 2003 Nov; 127(11):1451-7. PubMed ID: 14567724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
    Masci G; Agostinetto E; Giordano L; Bottai G; Torrisi R; Losurdo A; De Sanctis R; Navarria P; Scorsetti M; Zuradelli M; de Rose F; Bello L; Santoro A
    Future Oncol; 2020 Mar; 16(7):269-279. PubMed ID: 32043375
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.
    Choi MK; Park YH; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):521-9. PubMed ID: 25047725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
    Ben-Zion Berliner M; Yerushalmi R; Lavie I; Benouaich-Amiel A; Tsoref D; Hendler D; Goldvaser H; Sarfaty M; Rotem O; Ulitsky O; Siegal T; Neiman V; Yust-Katz S
    Breast Cancer Res Treat; 2021 Jan; 185(2):423-432. PubMed ID: 33037977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.